Current Perspectives on Letermovir and Maribavir for the Management of Cytomegalovirus Infection in Solid Organ Transplant Recipients
Raymund R Razonable1,2 1Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, MN, USA; 2William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN, USACorrespondence: Raymund R Razonable, Email razonable.raymund@m...
Saved in:
Main Author: | Razonable RR (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir
by: Jocelyne Piret, et al.
Published: (2024) -
The Use of Letermovir for Ganci clovi r-Res istan t Cytomegalovirus in Kidney Transplant Recipients
by: Nikolina Bašić-Jukić, et al.
Published: (2022) -
Evaluating the Safety of Maribavir for the Treatment of Cytomegalovirus
by: Gandhi RG, et al.
Published: (2022) -
Human cytomegalovirus infections in solid organ transplant recipients: an updated review / Mohd Fahmi Mastuki ... [et al.]
by: Mastuki, Mohd Fahmi, et al.
Published: (2022) -
SOLID ORGAN TRANSPLANT CANDIDATES AND RECIPIENTS: DENTISTS' PERSPECTIVE
by: Birsay Gümrü, et al.
Published: (2021)